Validity and reliability of the Turkish version of the central sensitization inventory

Basit Öğe Kaydı
dc.authorwosidIs, Enes Efe/HCH-8101-2022
dc.contributor.authorKeles, Ela Duzce
dc.contributor.authorBirtane, Murat
dc.contributor.authorEkuklu, Galip
dc.contributor.authorKilincer, Cumhur
dc.contributor.authorCaliyurt, Okan
dc.contributor.authorTastekin, Nurettin
dc.contributor.authorIs, Enes Efe
dc.date.accessioned2024-06-12T10:56:01Z
dc.date.available2024-06-12T10:56:01Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjectives: The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals. Patients and methods: Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0 +/- 8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8 +/- 9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8 +/- 10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application. Results: The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals. Conclusion: This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.en_US
dc.identifier.doi10.46497/ArchRheumatol.2021.8665
dc.identifier.endpage526en_US
dc.identifier.issn2618-6500
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85127204862en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage518en_US
dc.identifier.trdizinid511481en_US
dc.identifier.urihttps://doi.org/10.46497/ArchRheumatol.2021.8665
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/511481
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19647
dc.identifier.volume36en_US
dc.identifier.wosWOS:000754612600006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherTurkish League Against Rheumatismen_US
dc.relation.ispartofArchives Of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCentral Sensitization Inventoryen_US
dc.subjectReliabilityen_US
dc.subjectTranslationen_US
dc.subjectValidityen_US
dc.subjectCentral Sensitivity Syndromesen_US
dc.subjectPainen_US
dc.titleValidity and reliability of the Turkish version of the central sensitization inventoryen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu